During the past decade, PhysiqueMed Clinical Trials conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 4 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "PhysiqueMed Clinical Trials" #1 collaborator was "Eli Lilly and Company" with 1 trials as a collaborator and "Medpace, Inc." with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "PhysiqueMed Clinical Trials" are "Crohn Disease" (2 trials), "Chronic Kidney Disease (CKD)" (1 trials), "Diabetes Mellitus, Type 2" (1 trials), "Gout" (1 trials) and "Hypertension" (1 trials). Many other conditions were trialed in "PhysiqueMed Clinical Trials" in a lesser frequency.

Most popular intervention types in "PhysiqueMed Clinical Trials" are "Drug" (5 trials) and "Behavioral" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "GED-0301" (2 trials), "Diet" (1 trials), "Empagliflozin high dose" (1 trials) and "Empagliflozin low dose" (1 trials). Other intervention names were less common.

The vast majority of trials in "PhysiqueMed Clinical Trials" are 5 trials for "All" genders.

Currently, there are NaN active trials in "PhysiqueMed Clinical Trials". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in PhysiqueMed Clinical Trials, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in PhysiqueMed Clinical Trials, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".